ZymoGenetics is focused on the discovery, development, manufacture and commercialization
of therapeutic proteins for the treatment of human disease. Thanks to a robust
discovery program, promising drug pipeline
and strong development capabilities, ZymoGenetics
is an emerging leader among biotherapeutic
companies.
ZymoGenetics is:
Dedicated to the development of
protein drugs. We are committed
to developing protein drugs for the treatment
of human diseases. Our growing pipeline
of protein drug candidates spans multiple
therapeutic areas.
Focused on promising protein categories.
We work on a defined subset of genes that
we believe has the highest probability of
coding for proteins with therapeutic potential.
Successful
at discovering and developing therapeutic
proteins. A biotechnology veteran,
ZymoGenetics has contributed to the discovery
or development of six recombinant protein
products now marketed by other companies.
Expert at discovering novel protein
therapeutics. Our protein chemists
and molecular and cellular biologists
work at the center of a robust discovery engine
with a long and impressive track record.
They are the experts who turn our novel
protein discoveries into product candidates.
A leader in intellectual property
relating to potential therapeutic proteins.
One of the first companies to concentrate
solely on therapeutic proteins, ZymoGenetics
has amassed an extensive patent portfolio
of more than 300 issued or allowed U.S.
patents.
Corporate
Profile Passion
for Proteins
|
Back to top
